---
title: "Cell-based Assays – Cytotoxicity"
canonical: "https://www.pharmalegacy.com/services/in-vitro-platform/cell-based-assay-cytotoxicity/"
lastmod: "2026-05-26T01:44:03+00:00"
generator: "llm-mirrors/1.0.19"
---

Cell-based cytotoxicity assays have the potential to turn previously indiscriminate treatments into selective and accurate ones, sparing healthy cells. These assays grant you deep insights into your drug’s cellular impact, unveiling its strengths and weaknesses. By understanding how it interacts with life at its most fundamental level, you can pave the way for safer, more effective treatments that fulfill this vision. Each cell represents a tiny stepping stone on the path to a healthier future, and our assays ensure every step is taken with confidence and clarity.
Cell Line Selection:

Drug-resistant cell lines, enabling studies on specific resistance mechanisms.
Investigate drug interactions using our combination drug testing, uncovering potential synergies and optimizing treatment strategies.
Over 200 tumor cell lines available, encompassing a diverse range of cancers and genetic backgrounds.

Experimental Design:

2D and 3D cell culture models available
Diverse readout options available, including MTT, cck8, CTG, Brdu, and more.
Flexible treatment times, ranging from acute exposures to chronic dosing (up to 14 days)